Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Cancer Research|November 1, 1979
Induction of hepatic neoplastic lesions in mice with a single dose of hycanthone methanesulfonate after partial hepatectomyH Tsuda, D S Sarma, S Rajalakshmi, et al.Journal of Toxicology and Environmental Health|November 1, 1975
Dissociation of mutagenic and other toxic properties from schistosomicidesE BuedingThe Journal of Parasitology|February 1, 1979
Glycogen synthase of Hymenolepis diminuta. II. Nutritional state, interconversion of forms, and primer glycogen molecular weight as control factorsP A Mied, E BuedingJournal of Chromatography|August 12, 1983
Identification and quantitation of a metabolite of anethol dithiolthione in rat and mouse urine using high-performance liquid chromatographyA N Masoud, E BuedingThe Journal of Parasitology|February 1, 1979
Glycogen synthase Hymenolepis diminuta. I. Allosteric activation and inhibitionP A Mied, E BuedingThe American Journal of Tropical Medicine and Hygiene|November 1, 1978
Recovery of the hepatic drug-metabolizing capacity in mice infected with Schistosoma mansoni following curative chemotherapy with the schistosomicide 4-isothiocyano-4'-nitro-diphenylamine (CGP 4540)Y N Cha, E BuedingScience (New York, N.Y.)|June 4, 1971
Hycanthone resistance: development in Schistosoma mansoniS H Rogers, E BuedingCarcinogenesis|August 1, 1986
Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustardL W Wattenberg, E BuedingThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1976
Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoniW H Haese, E BuedingPageof 6